penicillanic acid has been researched along with Colonic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meibohm, AR; Teppler, H; Woods, GL | 1 |
| de la Hunt, MN; Karran, SJ | 1 |
2 trial(s) available for penicillanic acid and Colonic Diseases
| Article | Year |
|---|---|
Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Colonic Diseases; Demography; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Severity of Illness Index | 2004 |
Sulbactam/ampicillin compared with cefoxitin for chemoprophylaxis in elective colorectal surgery.
Topics: Aged; Ampicillin; Cefoxitin; Colonic Diseases; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Premedication; Prospective Studies; Random Allocation; Rectal Diseases; Sulbactam; Surgical Wound Infection | 1986 |